A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Elimination
According to TikTok, the platform has removed problematic material and banned related hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.
Online Trading Operations
Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a vendor posted contact information, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, health issues or previous experience.
Item Details and Costs
Within these groups, posts show black plastic parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the research behind this drug is valid, these online products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may subject users to potentially serious medical dangers”.
